In follow up to the notice of February 27, 2020 cracking down on malicious epidemic-related trademark applications, the Chinese Trademark Office has announced the rejection of 63 malicious trademarks for the names of Wuhan hospitals and other epidemic-related marks and 37 malicious trademarks for “Li Wenliang,” one of the Wuhan doctors that initially warned of the virus and later succumbed to it.
The China National Intellectual Property Administration (CNIPA) announced on March 4, 2020 that late fees for missed patent annuity payments will be waived if caused by the coronavirus epidemic. This expands on Bureau Announcement 350, which explained that patentees and applicants can restore their patent rights without payment of a restoration right request fee if lost rights were due to the coronavirus.
The following Chinese Intellectual Property law seminars may be of interest: Webinar: 10 Things to Know About the Chinese Patent Process March 12, 2020 How does Chinese patent practice compare to practice in the United States? Find out in a complimentary webinar presented by Aaron Wininger. The webinar will cover practice issues including expediting patent prosecution, reducing fees, formalities requirements peculiar to the CNIPA, and claim drafting. The emphasis will be on explaining CNIPA patent practice while highlighting the differences from …
In a notice dated February 27, 2020, the Chinese Trademark Office announced issuance of the Guidelines for the Examination of Epidemic Prevention and Control-Related Trademarks, which provides guidance on the examination of marks for the names of people involved in the epidemic, marks related to the epidemic virus and disease, marks related to epidemic-related drugs, marks for protective products (e.g., respirators), and other marks related to the epidemic.